Cargando…
A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity
The clinical use of the anthracycline doxorubicin is limited by its cardiotoxicity which is associated with mitochondrial dysfunction. Redox cycling, mitochondrial DNA damage and electron transport chain inhibition have been identified as potential mechanisms of toxicity. However, the relative roles...
Autores principales: | de Oliveira, Bernardo L., Niederer, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117565/ https://www.ncbi.nlm.nih.gov/pubmed/27870850 http://dx.doi.org/10.1371/journal.pcbi.1005214 |
Ejemplares similares
-
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022) -
Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
por: Chen, Rui, et al.
Publicado: (2023) -
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
por: Christidi, Effimia, et al.
Publicado: (2021) -
PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study
por: Detmer, Felicitas J., et al.
Publicado: (2022) -
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
por: Maccarinelli, Federica, et al.
Publicado: (2014)